Latest Reported Offering
$20,000
Target Amount
$4,999,999
Maximum Amount
2026-09-24
Deadline
Security Details
Type: Other
Price per share: $0.79
Price set by: N/A
Shares offered: 25,316+
Offering Costs
Cash commission: —
7 - 13 percent
Equity compensation: —
One percent (1%) of securities of the total amount of investments raised in the offering, along the same terms as investors.
Filing history
Form C family — 9 filingsThe reported figures behind Oxeia Biopharmaceuticals, Inc.
Form C prints a most-recent and a prior fiscal year side by side but never names them. The dashboard chains every filing into those years and plots them. EDGAR still has each Form C-AR; the dashboard lays every year they filed next to it.
- Reported financials chained into fiscal years — revenue, income, assets, cash — not one filing at a time
- A sparkline on each figure so the shape is visible before the numbers
- A revenue series dated to the filings that reported it
- The campaign as filed: target, ceiling, deadline, and the portal that ran it
- Follow it, and see it change on your watchlist
Part of the Alts plan — $40/mo at launch pricing ($100 list)
Company Information
Legal Status
Corporation
Jurisdiction
Delaware
Date of Incorporation
2014-03-19
Latest Metrics
Employees2
Total Assets$260,456
Cash on Hand$2,905
Revenues$0.00
Net Income-$1,246,701
Crowdfunding Portals
The intermediary named in this company’s Form C filings. Investments in a Regulation Crowdfunding offering can only be made through them.